Literature DB >> 3103294

The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.

J R Thistlethwaite, B W Haag, A O Gaber, J K Stuart, A J Aronson, J T Mayes, D M Lloyd, F P Stuart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3103294

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  The role of OKT3 in clinical transplantation.

Authors:  D J Norman; M R Leone
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 2.  Lymphocyte subpopulations.

Authors:  R J Powell; J S Jenkins
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

Review 3.  Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 4.  Monoclonal antibodies in gynecological cancer: a critical point of view.

Authors:  Filippo Bellati; Chiara Napoletano; Maria Luisa Gasparri; Valeria Visconti; Ilaria Grazia Zizzari; Ilary Ruscito; Jlenia Caccetta; Aurelia Rughetti; Pierluigi Benedetti-Panici; Marianna Nuti
Journal:  Clin Dev Immunol       Date:  2011-12-26

Review 5.  Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents.

Authors:  John C Rohloff; Amy D Gelinas; Thale C Jarvis; Urs A Ochsner; Daniel J Schneider; Larry Gold; Nebojsa Janjic
Journal:  Mol Ther Nucleic Acids       Date:  2014-10-07       Impact factor: 10.183

Review 6.  Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.

Authors:  Zhiqiang An
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.